NCT00144664View on ClinicalTrials.gov

Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

PHASE3CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

April 30, 2005

Study Completion Date

October 31, 2005

Conditions
Systemic Juvenile Idiopathic Arthritis
Interventions
DRUG

MRA(Tocilizumab)

Sponsors
All Listed Sponsors
lead

Chugai Pharmaceutical

INDUSTRY